103 filings
Page 2 of 6
8-K
ewdrtzujwbl2
29 Oct 20
Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update
4:30pm
425
qc6xra 4rle2skor
6 Oct 20
Business combination disclosure
9:46pm
8-K
t12 dhm80v
6 Oct 20
Entry into a Material Definitive Agreement
9:35pm
425
ijjofq
6 Oct 20
Business combination disclosure
9:11pm
425
etqywf
5 Oct 20
Business combination disclosure
9:58pm
425
gd15x 3sjjc
5 Oct 20
Business combination disclosure
4:14pm
425
rrr539ue9
5 Oct 20
Business combination disclosure
4:10pm
8-K
yvv2dzhg9 rjw1l6
5 Oct 20
Bridgebio Pharma and Eidos Therapeutics Announce Merger Agreement
4:06pm
8-K
dvgkk8b pleho8zx9isg
29 Sep 20
Regulation FD Disclosure
7:15am
8-K
c7p1mqmzdih
7 Aug 20
Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of Directors
4:56pm
8-K
tzsgpad4n u1cqkv6jgz
6 Aug 20
Eidos Therapeutics Reports Second Quarter 2020 Financial Results and Business Update
4:33pm
UPLOAD
x99jufeh
8 Jul 20
Letter from SEC
12:00am
CORRESP
3p39f9swd g2f0zlz3oq
1 Jul 20
Correspondence with SEC
12:00am
UPLOAD
gse3ailtx iz1
22 Jun 20
Letter from SEC
12:00am
S-8
cjlypden
9 Jun 20
Registration of securities for employees
4:01pm
8-K
zjo a9ii91
1 Jun 20
Departure of Directors or Certain Officers
4:05pm
8-K
fukfjnj2qluofp3rdslm
8 May 20
Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business Update
4:30pm